A wild fungal strain of Aspergillus terreus, labeled as PM3, was isolated by using the Candida albicans bioassay and confirmed by 18S r DNA analyses. Lovastatin was produced by submerged and solid state fermentations. Of the 30 isolated fungal strains, 11 showed lovastatin production with Aspergillus terreus PM3 being the best with a yield of 240 mg/L at the 10 th day of submerged fermentation. Carboxymethylcellulose had a stimulatory effect on lovastatin production. It restricted uncontrolled filamentous growth, induced pellet formation and, thereby, improved lovastatin yield. In solid state fermentation (SSF), of the agro wastes from five crops (bran of wheat and rice, husks of red gram and soybean, and green gram straw), wheat bran showed maximum lovastatin production (12.5 mg/g of dry substrate) at pH 7.1 and a temperature of 30±2°C. Development of a lovastatin production process based on wheat bran as a substrate in SSF is economically attractive as it is a cheap and readily available raw material in agriculture-based countries.
Hypercholesterolemia is a major contributor to atherosclerosis and its clinical sequelae, myocardial infarction, ischemic stroke and peripheral vascular diseases [1] . During the past two decades, cholesterol control by a variety of drugs has yielded a significant reduction in cardiovascular mortality [2] . Since more than two thirds of total body cholesterol is synthesized de novo, inhibition of biosynthesis is considered as an important way to control its level in the blood [3] . Statins, a class of fungal secondary metabolites, competitively inhibit 3-hydroxyl-3-methylglutaryl coenzyme-A reductase (HMG-CoA reductase), the rate limiting step in cholesterol biosynthesis, significantly lowering the blood cholesterol level in humans and animals, and thus becoming the compound of choice for the purpose. Mevastatin was the first statin to be discovered as a secondary metabolite of Penicillium citrinum. Lovastatin also restricts the growth of tumor cells by inhibiting isoprenoid biosynthesis and was the first statin approved by the FDA as a cholesterol lowering drug [3] . The lactone form of lovastatin is inactive and water insoluble, while the β-hydroxy acid form is active and water soluble. In fermentation broths, 90% lovastatin exists in the latter form. The hypocholesterolemic activity of the β-hydroxyl acid form of lovastatin is due to its structural similarity to HMG-CoA, which is the natural substrate of the enzyme. Lovastatin is also known to decrease cholesterol in hepatocytes by increasing HDL (high density lipoprotein) and decreasing LDL (low density lipoprotein) [4, 5] .
Lovastatin is generally produced using batch fermentations of Aspergillus terreus [3] . Fed batch fermentations were found to be superior to batch cultures for its production [6] .
Of late, considerable interest has been generated in solid state (substrate) fermentation (SSF) as a potential alternative to submerged fermentation (SmF) for the production of secondary metabolites because it uses economic substrates (agro residues) [7] . Other advantages include higher lovastatin yields; diminished catabolite repression, and better product stability [8] . Moreover, the process is more energy efficient, environment friendly and requires fewer and simpler downstream processing steps and measures [6] . The present paper describes lovastatin production by SmF and SSF and evaluates various parameters affecting the yield. Since the β-hydroxy acid form of lovastatin also exhibits antifungal activity, it has been exploited to evaluate its production by wild isolates using a rapid and reliable Candida albicans bioassay.
Of the 30 isolated fungal strains, 11 showed inhibition of C. albicans growth and 3 of them, identified as Aspergillus terreus, and labeled as PM3, PM6, and PM11, exhibited 17, 14 and 16 mm zones of inhibition, respectively in the bioassay. The bioassay with C. albicans showed uniform growth in plates with distinct lovastatin and agar plug extract. Wells filled with only ethyl acetate did not show any zone of inhibition. The diameters of the zones of inhibition were directly proportional to the amount of lovastatin produced by the respective strain. Aspergillus terreus ATCC 20542, used as a marker standard in this study, showed the highest zone of inhibition and maximum lovastatin titer, followed by the 3 isolated strains ( Table  1 ).The lovastatin producing ability of the isolated strains was confirmed by fermentations at shake flask level. The lovastatin yield of isolated strain PM3 was comparable with that of the commercially used strain of A. terreus ATCC 20542 (Table 1 ) and, therefore, it was used in all further experiments. The highest lovastatin titer was obtained in batch cultures when spherical mycelial pellets were used as inoculum with aeration at 200 rpm.
The time course of lovastatin production was monitored at 24 hour intervals by HPLC and the fermentation profile is shown in Figure 1 .The highest lovastatin (240 mg/L) and biomass (20 g/L) in batch cultures were obtained on the 10 th day of fermentation after which they showed a declining trend. The residual sugar concentration did not show a significant decline in the first two days. The final pH at the end of fermentation was 7.2. The HPLC profile of the fermentation broth of A. terreus PM3 showed a single, sharp and symmetrical peak at a retention time of 6.8 min. (open hydroxyacid form), which is comparable with standard lovastatin with respect to both retention time and absorption at 238 nm, in agreement with previous findings [11] .
The morphology of the mycelia during the course of fermentation has a profound effect on lovastatin production in batch fermentation. The composition of the production media plays an important role in maintaining the morphology, length and size of the hyphae. Generally, filamentous growth of mycelia is observed with rapidly metabolizing carbon sources in the medium [9] . Use of some complex biopolymers restricts the filamentous growth of the fungus and induces pellet formation, which in turn, improves the oxygen and mass transfer and yield of product in the fermentation [7] . Carboxymethylcellulose, at 1% concentration, along with lactose in the medium in our studies induced pellet formation with a yield of 252 mg/l lovastatin ( Figure 2 ). The other biopolymers, like starch, gelatin and alginate, did not show a stimulatory effect on lovastatin production.
Lovastatin production by the isolated strain PM3, with different solid supports in SSF, is shown in Table 2 . Of the agro residues, wheat bran supported maximum lovastatin production (12.5 mg/g, dry solid), probably because it contains sufficient nutrients and is able to remain loose, even in moist conditions, thereby providing a large surface area [7] . The time course of lovastatin production with wheat bran as solid support showed a maximum titer on the 6 th day of the experiment. Similarly, lovastatin titers were the highest (12.5 mg/g, dry solid) and lowest (7.1 mg/ g, dry solid) at moisture contents of 70% and 40% in the support medium, respectively ( Figure 3 ). A higher than optimum moisture level causes decreased porosity, alteration in wheat bran particle structure, gummy texture, lower oxygen transfer and enhancement of the formation of aerial mycelia [7] . On the other hand, a lower than optimum moisture level leads to reduced solubility of the nutrients of the solid substrate, a lower degree of swelling, and a higher water tension [12] . The pH of water used to maintain the moisture content of the matrix also influenced the lovastatin production. The yield was maximum (12.5 mg/g, dry solid) at pH 7.1 with wheat bran as the solid support.
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Lovastatin titre (mg/ L) In conclusion, the C. albicans bioassay was employed for screening the lovastatin producing fungal strain from natural sources. The bioassay can be used as a rapid method for isolating lovastatin producing fungi as it requires an incubation time of 16-18 h, which is substantially less than that required in the conventional method using Neurospora crassa [13] . One of the isolates, identified as A. terreus and labeled as PM3, showed lovastatin production in both SmF and SSF. There are obvious advantages of using SSF over SmF for secondary metabolite production [12, 14] . The lovastatin yield by the isolate in SmF was almost comparable with that of the standard strain, ATCC 20542. This makes it a potential candidate for strain improvement for higher lovastatin yields for commercial exploitation.
Experimental
Isolation and screening of microorganisms:
Fungal strains were isolated from 35 soil samples collected from different regions of north Maharashtra, India. All strains were maintained on Czapek Dox agar slants at 28ºC. Identification was carried out on the basis of morphological characters and 18 S r DNA analyses at NCCS, Pune.
Bioassay: Candida albicans ATCC 4561 obtained from the National Culture for Industrial Microorganisms (NCIM), Pune was maintained on potato dextrose agar (PDA) slants and used for bioassay, for which 100 mL medium was used of the following composition (g): lactose, 60; soybean meal, 25; corn steep liquor, 5; KH 2 PO 4 , 2; K 2 HPO 4 , 1; MgSO 4 .7H 2 O, 0.5; FeSO 4 .4H 2 O, 1; NaNO 3 , 0.5; MnSO 4 .7H 2 O, 0.5; and agar, 15. The medium was autoclaved, the pH adjusted to 7.0 and poured into pre-sterilized flat bottomed glass Petri plates (Borosil, India) to solidify. The agar plugs were prepared using a sterile 10 mm diameter cork borer. Three agar plugs were then transferred to each glass slide (3 × 1 inch) in the sterile Petri plate containing Whatmann filter paper no 1. The spores collected from the 10 day old slant of isolates were scrubbed in sterile 2% tween 80 using a wire loop to form a spore suspension. The agar plugs were then inoculated by dipping into spore suspension using sterile forceps and placed on the surface of the glass slide. To prevent drying of the agar plugs, the humidity was maintained by adding 5 mL sterile distilled water to the Whatmann filter papers in the Petri dishes and incubated in a humidity chamber at 28ºC for 4 days. After incubation, agar plugs were transferred to screw capped test tubes containing 2 mL ethyl acetate and macerated with a sterile glass rod and kept for 3 h [6] . The resulting suspension was centrifuged and the solids were removed by filtration, followed by centrifugation. Candida albicans was grown for 4 days on a PDA plate and the cell count was optimized to 2 × 10 2 cells/mL. An aliquot of 0.1 mL of a 24 h old culture was spread over the surface of an agar plate using a sterile glass spreader. Wells were prepared by using a 6 mm diameter sterile cork borer; 0.5 mL extracted sample was added to each well in a laminar air flow unit. Ethyl acetate (0.5 mL) and the β-hydroxy acid form of lovastatin (0.5 mL) served as control and standard, respectively. Plates were kept in a refrigerator for 15 min for diffusion, and incubated for 48 h at 37 0 C before the zone of inhibition was recorded. All experiments were carried out in triplicate and results are shown as mean ± SD.
Inoculation and culture conditions:
The isolates showing the biggest zones of inhibition in the bioassay against Candida albicans were selected and maintained on PDA agar. After inoculation from the original slant, plates were incubated at 28ºC for 5 days. A suspension of spores was obtained by scrubbing the plate with 5 mL of a sterile aqueous solution of 2% tween 80. The spore concentration was optimized to 10 6 spores/mL by using a Neubaueur hemocytometer. Seed was developed by inoculating 5 mL spore suspension in a 250 mL Erlenmeyer flask containing (g): lactose, 60; soybean meal, 25; KH 2 PO 4 , 2; K 2 HPO 4 , 1; MgSO 4 .7H2O, 0.5; FeSO 4 .4H 2 O, 1; NaNO 3 , 0.5; and MnSO 4 .7H 2 O, 0.5 [6, 7] . After developing sufficient biomass, 8% of inoculam was transferred to production medium of the same composition. The pH of the medium was maintained at 6.5 (after sterilization). All fermentations were carried out at 28ºC and 200 rpm for 10 days on a rotary shaker (Steelmate Novatech, India) in 500 mL shake flasks containing 150 mL of production medium [7, 9] .
Effect of carboxymethylcellulose:
Production medium (100 mL) was separately supplemented with an increasing concentration of CMC (0.2-1.4 g %), seeded with 8% inoculum, and incubated on a rotary shaker at 200 rpm at room temperature. The effect was checked against lactose and soybean meal as a carbon and nitrogen source, respectively. After a 24 h interval, the cell mass was harvested form each flask and lovastatin yield was determined by HPLC.
Lovastatin production by solid state fermentation:
Experiments were performed using different solid agro residues like bran of wheat and rice, husks of red gram and soybean, and green gram straw to evaluate their support of lovastatin production. Good quality, low density agro residues were washed twice thoroughly with boiling water, sun dried and cut into small pieces (a range of 2 -3.5 mm particles). Glass bottles (15 × 6.5 cm) with a nominal volume of 200 mL were filled with 10 g of the respective solid matrix and distilled water was added to provide different (50, 60, 70 and 80%) moisture levels. Inoculation was made under aseptic conditions by using 10 8 spores per g of solid matrix and the bottles were incubated at 25ºC. The effect of initial pH on lovastatin production was studied by adjusting the pH between 3 and 10 using either 1 N H 2 SO 4 or 1 N NaOH added in distilled water. Experiments were undertaken in triplicate and average values with standard errors are reported.
Biomass and lovastatin recovery:
After every 24 h interval in SmF, a 5 mL sample was withdrawn and the biomass separated by centrifugation, dried and weighed. The clear supernatant was filtered through a 0.45µm membrane filter and acidified to pH 3 with 0.1 N HCl and kept on a rotary shaker for 1 h at room temperature. Extraction was carried out with 1:1 ethyl acetate in a separating funnel, and the organic phase was collected. The extracts were dried, concentrated in a spray dryer, and analysed.
The fermented material in SSF was extracted by adding a methanol: water mixture (1:1, v/v) of pH 7.7 to the glass bottles. Extraction was conducted at 30 o C in a rotary shaker at 200 rpm for 2 h, after which the mixture was centrifuged at 10,000 rpm for 10 min in a cooling centrifuge and the supernatant filtered through a 0.75µm membrane filter [7] . The lovastatin in the clear extract was estimated by HPLC.
Lovastatin and residual sugar analyses:
Lovastatin is synthesized in its β-hydroxyacid form in fermentation broth and was measured by HPLC, where it elutes earlier than its lactone form. The purified fermented broth was diluted 5 times with acetonitrile and demonized water (1:1). The standard was prepared by converting the lactone form of lovastatin (10 mg) to the β-hydroxy acid form by dissolving it in 0.1 N NaOH and ethanol (1:1), heating at 50 o C for 20 min and neutralizing with 0.1 N HCl. The resulting stock solution containing 1 mg/mL lovastatin was maintained at 5 o C. HPLC was performed on a Jupiter phenomenix 250 × 4.60 mm, 4μm column with LC 20AT liquid chromatograph (Shimadzu, Japan), equipped with a Shimadzu SOD -M20A PDA detector. A 20 µL sample was injected and the chromatograph developed with a 1:1 mixture of acetonitrile and deionized water at a flow rate of 2 mL/ minute and with a detection wavelength of 238 nm [11] . Residual sugars were determined spectrophotometrically (Model 1650, Shimadzu, Japan) by the DNSA method [10].
Chemicals and reagents:
Pharmaceutical grade lovastatin (lactone form) was a generous gift from Ranbaxy Laboratories, India. HPLC grade ethyl acetate and acetonitrile were supplied by Qualigens Fine Chem., Mumbai.
